Institutional Ownership Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND). We have compiled data on the 276 institutions that hold shares in the stock, with a total of 60 Million shares, which have been reported (via 13F filing form) to have a value of $12.3 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Td Asset Management Inc
|
Jul 28, 2025 Q2 2025 |
292,090
shares
|
$59.3 Million
0.05% of portfolio
|
Q2 2025
Reduced 14.94%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Aug 05, 2025 Q2 2025 |
276,984
shares
|
$56.2 Million
0.12% of portfolio
|
Q2 2025
Reduced 16.1%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Aug 14, 2025 Q2 2025 |
263,267
shares
|
$53.4 Million
0.18% of portfolio
|
Q2 2025
Reduced 23.92%
|
|
|
Q Global Advisors, LLC
Fort Worth, TX |
Aug 14, 2025 Q2 2025 |
255,000
shares
|
$51.7 Million
37.03% of portfolio
|
Q2 2025
Added 2.46%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
254,785
shares
|
$51.7 Million
0.0% of portfolio
|
Q2 2025
Reduced 86.62%
|
|
|
Camber Capital Management LP
Boston, MA |
Aug 14, 2025 Q2 2025 |
250,000
shares
|
$50.7 Million
4.25% of portfolio
|
Q2 2025
Reduced 28.57%
|
|
|
Siren, L.L.C.
New York, NY |
Aug 13, 2025 Q2 2025 |
245,943
shares
|
$49.9 Million
2.2% of portfolio
|
Q2 2025
Reduced 14.41%
|
|
|
Sei Investments CO
Oaks, PA |
Aug 14, 2025 Q2 2025 |
236,570
shares
|
$48 Million
0.05% of portfolio
|
Q2 2025
Reduced 8.31%
|
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
221,754
shares
|
$45 Million
3.63% of portfolio
|
Q2 2025
Added 18.64%
|
|
|
Victory Capital Management Inc
|
Aug 13, 2025 Q2 2025 |
219,118
shares
|
$44.5 Million
0.03% of portfolio
|
Q2 2025
Added 75.4%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
217,000
shares
|
$44 Million
2.54% of portfolio
|
Q2 2025
Added 0.46%
|
|
|
Ars Investment Partners, LLC
|
Aug 11, 2025 Q2 2025 |
209,930
shares
|
$42.6 Million
3.45% of portfolio
|
Q2 2025
Reduced 20.83%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
201,044
shares
|
$40.8 Million
0.04% of portfolio
|
Q2 2025
Added 83.38%
|
|
|
Allspring Global Investments Holdings, LLC
|
Jul 25, 2025 Q2 2025 |
200,257
shares
|
$40.6 Million
0.06% of portfolio
|
Q2 2025
Added 5.61%
|
|
|
Vestal Point Capital, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
200,000
shares
|
$40.6 Million
1.82% of portfolio
|
Q2 2025
Added 33.21%
|
|
|
Candriam S.C.A.
|
Aug 08, 2025 Q2 2025 |
195,115
shares
|
$39.6 Million
0.2% of portfolio
|
Q2 2025
Reduced 19.63%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
195,108
shares
|
$39.6 Million
0.33% of portfolio
|
Q2 2025
Added 28.51%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
185,122
shares
|
$37.6 Million
0.0% of portfolio
|
Q1 2025
Added 139.09%
|
|
|
New York State Common Retirement Fund
|
Aug 13, 2025 Q2 2025 |
182,558
shares
|
$37 Million
0.04% of portfolio
|
Q2 2025
Reduced 10.72%
|
|
|
Catalio Capital Management, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
179,926
shares
|
$36.5 Million
6.51% of portfolio
|
Q2 2025
Reduced 7.98%
|
|
|
Resolute Capital Asset Partners LLC
Denver, CO |
Aug 14, 2025 Q2 2025 |
160,672
shares
|
$32.6 Million
15.61% of portfolio
|
Q2 2025
Reduced 4.08%
|
|
|
Rice Hall James & Associates, LLC
|
Aug 11, 2025 Q2 2025 |
160,110
shares
|
$32.5 Million
1.64% of portfolio
|
Q2 2025
Reduced 0.43%
|
|
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
Aug 14, 2025 Q2 2025 |
154,176
shares
|
$31.3 Million
0.09% of portfolio
|
Q2 2025
New holding
|
|
|
Loomis Sayles & CO L P
|
Aug 13, 2025 Q2 2025 |
148,497
shares
|
$30.1 Million
0.03% of portfolio
|
Q2 2025
Reduced 15.1%
|
|
|
Tri Locum Partners LP
New York, NY |
Aug 14, 2025 Q2 2025 |
147,642
shares
|
$30 Million
9.17% of portfolio
|
Q2 2025
Added 356.74%
|